Expanding anti-CD38 immunotherapy for lymphoid malignancies.
- DOI
- 10.1186/s13046-022-02421-2
- Published
- 2022 Jun 28
- Container
- Journal of experimental & clinical cancer research : CR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-022-02421-2,
title = {Expanding anti-CD38 immunotherapy for lymphoid malignancies.},
author = {Wang X and Yu X and Li W and Neeli P and Liu M and Li L and Zhang M and Fang X and Young KH and Li Y},
year = {2022},
journal = {Journal of experimental \& clinical cancer research : CR},
doi = {10.1186/s13046-022-02421-2},
url = {https://doi.org/10.1186/s13046-022-02421-2}
}RIS
TY - JOUR TI - Expanding anti-CD38 immunotherapy for lymphoid malignancies. AU - Wang X AU - Yu X AU - Li W AU - Neeli P AU - Liu M AU - Li L AU - Zhang M AU - Fang X AU - Young KH AU - Li Y PY - 2022 JO - Journal of experimental & clinical cancer research : CR DO - 10.1186/s13046-022-02421-2 UR - https://doi.org/10.1186/s13046-022-02421-2 ER -
APA
X, W., X, Y., W, L., P, N., M, L., L, L., M, Z., X, F., KH, Y., & Y, L. (2022). Expanding anti-CD38 immunotherapy for lymphoid malignancies.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-022-02421-2
Source records
- pubmed · retrieved 2026-11-10T12:10:42.978Z